Historical record - last NADAC effective date: 11/18/2020
Product Information
MONTELUKAST SOD 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0730 per EA under NDC 57237025530. Its NADAC has been published 174 times since Aug 9, 2017.
FDA first approved this application on Aug 3, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237025530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/18/2020
Active Ingredients
MONTELUKAST SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202468FDA Approved
8/3/2012
TE Code
AB
On Market Since
8/3/2012
Pharmacological Classes
Price Statistics
The NADAC for MONTELUKAST SOD 10 MG TABLET has been published 174 times since Aug 9, 2017, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0730 per EA |
|---|---|
| All-time high | $0.0950 (Dec 13, 2017) |
| All-time low | $0.0553 (Apr 17, 2019) |
| Median price | $0.0667 |
| Average price | $0.0711 |
| Largest weekly change | -19.7% (Nov 21, 2018) |
| Weeks tracked | 174 |
| Tracking since | Aug 9, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-22.9%
Last surveyed Dec 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Montelukast Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukotriene Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MONTELUKAST SOD 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0730 per EA (NDC 57237025530), effective Dec 2, 2020.
How has the price of MONTELUKAST SOD 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for MONTELUKAST SOD 10 MG TABLET has declined 22.9%. It has been tracked across 174 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 10 MG TABLET?
Since Aug 9, 2017, the NADAC for MONTELUKAST SOD 10 MG TABLET has ranged from a low of $0.0553 (Apr 17, 2019) to a high of $0.0950 (Dec 13, 2017), with a median of $0.0667 per EA.
Are there cheaper alternatives to MONTELUKAST SOD 10 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MONTELUKAST SOD 10 MG TABLET, is $0.0419 per EA — about 43% below MONTELUKAST SOD 10 MG TABLET.
Who manufactures MONTELUKAST SOD 10 MG TABLET?
MONTELUKAST SOD 10 MG TABLET (NDC 57237025530) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.